MTNB icon

Matinas BioPharma
MTNB

Overview Fund Activity

51 hedge funds and large institutions have $5.61M invested in Matinas BioPharma in 2023 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
51
Holders Change
+4
Holders Change %
+8.51%
% of All Funds
0.75%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
8
Reduced
10
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$2.01M
2
CCM
2
Connective Capital Management
California
$68.7K
3
AWA
3
Arkadios Wealth Advisors
Georgia
$351K
4
VF
4
Virtu Financial
New York
$35K
5
Renaissance Technologies
5
Renaissance Technologies
New York
$80K

Top Sellers

1
Jacobs Levy Equity Management
1
Jacobs Levy Equity Management
New Jersey
$0
2
Geode Capital Management
2
Geode Capital Management
Massachusetts
$341K
3
Wells Fargo
3
Wells Fargo
California
$50.1K
4
SIG
4
Sargent Investment Group
Maryland
$825K
5
Squarepoint
5
Squarepoint
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Bank of America
51
Bank of America
North Carolina
$58 +$58 +5 New
MSWM
52
McGlone Suttner Wealth Management
Wisconsin
$5 – – –
Jacobs Levy Equity Management
53
Jacobs Levy Equity Management
New Jersey
– -$98.1K -15,095 Closed
Squarepoint
54
Squarepoint
New York
– -$19.2K -2,961 Closed
Jane Street
55
Jane Street
New York
– -$4.49K -690 Closed
BBA
56
Baader Bank Aktiengesellschaft
Germany
– -$3.77K -671 Closed
SW
57
SlateStone Wealth
Florida
– -$1K -200 Closed
MFG
58
Magnus Financial Group
New York
– -$1.3K -200 Closed
1 2
3